Source: Annual Congress 2001 - Pulmonary thromboembolism and infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Adamek, P. Grzanka, M. Sanak, M. Krzanowski, E. Nizankowska, A. Szczeklik (Cracow, Poland). The genetic polymorphisms associated with acute pulmonary embolism (PE) and deep venous thrombosis (DVT). Eur Respir J 2001; 16: Suppl. 31, 2613

Member's Comments

No comment yet.

Related content which might interest you: Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012 Association between risk stratification for pulmonary embolism and deep vein thrombosis of lower extremities Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Risk of deep vein thrombosis and pulmonary embolism in asthma Source: Eur Respir J 2013; 42: 655-661 Year: 2013 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Clinical significance of deep venous thrombosis in symptomatic pulmonary embolism Source: International Congress 2017 – Pulmonary embolism Year: 2017 Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)? Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003 Modern treatment of pulmonary embolism Source: Eur Respir J 2002; 19: 22S-27S Year: 2002 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 The COPD frequency in patients with venous thrombosis Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Prognostic significance of asymptomatic pulmonary embolism in patients with deep vein thrombosis Source: Eur Respir J 2004; 24: Suppl. 48, 685s Year: 2004 Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Chronic thromboembolic pulmonary hypertension: update 2004 Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=243 Year: 2004 Deep venous thrombosis associated with pulmonary tuberculosis Source: Annual Congress 2007 - Difficult tuberculosis cases I Year: 2007 Anomalous pulmonary venous drainage (APVD) in patients with suspected pulmonary hypertension (PH) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Venous thromboemboli and exacerbations of COPD Source: Eur Respir J 2010; 35: 1243-1248 Year: 2010 Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016 Year: 2017 Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE) Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012